Treasurer of the State of North Carolina
MRTX

Treasurer of the State of North Carolina’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Treasurer of the State of North Carolina’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,258
Closed -$1.43M – 1016
2023
Q4 		$1.43M Buy
24,258
+4,210
+21% +$237K 0.01% 919
2023
Q3 		$873K Buy
20,048
+110
+0.6% +$3.93K ﹤0.01% 963
2023
Q2 		$720K Buy
19,938
+430
+2% +$17.7K ﹤0.01% 984
2023
Q1 		$725K Buy
19,508
+140
+0.7% +$6.3K ﹤0.01% 970
2022
Q4 		$878K Buy
19,368
+930
+5% +$60.2K 0.01% 956
2022
Q3 		$1.29M Buy
18,438
+240
+1% +$17.8K 0.01% 912
2022
Q2 		$1.22M Buy
18,198
+2,771
+18% +$176K 0.01% 940
2022
Q1 		$1.27M Buy
15,427
+248
+2% +$25.4K 0.01% 922
2021
Q4 		$2.23M Buy
15,179
+1,040
+7% +$161K 0.01% 787
2021
Q3 		$2.5M Buy
14,139
+479
+4% +$77.1K 0.01% 739
2021
Q2 		$2.21M Buy
+13,660
New +$2.19M 0.01% 791

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Treasurer of the State of North Carolina's MRTX Position: Q1 2024 in Review

Treasurer of the State of North Carolina sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 24,258 shares — an estimated $1.43M sold.

Treasurer of the State of North Carolina first reported a position in MRTX in Q2 2021 and held it in 11 quarters. The position peaked at $2.5M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Treasurer of the State of North Carolina reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 24,258 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.43M.
  • Treasurer of the State of North Carolina first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Treasurer of the State of North Carolina's Mirati Therapeutics, Inc. Common Stock position peaked at $2.5M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2024, filed 9 May 2024.